Kartik Ramamoorthi

Co-founder, Chief Executive Officer & Board Member @ Encoded Therapeutics arrow icon

About Kartik Ramamoorthi

Kartik Ramamoorthi is the co-founder and CEO of a biotech company, known for his educational background in neuroscience from MIT and Rutgers University, and his recognition in multiple prestigious under-40 lists.

Known information

Kartik Ramamoorthi serves as the co-founder, Chief Executive Officer, and a Board Member at his biotech firm. He completed his Ph.D. in Molecular & Cellular Neuroscience from the Massachusetts Institute of Technology (MIT) in 2014, after earning a B.S. in Cell Biology and Neuroscience from Rutgers University in 2008. Ramamoorthi was part of the foundational team at Voyager Therapeutics before establishing his own company. His contributions to the biotech field have been acknowledged widely, earning him spots on several notable lists including the San Francisco Business Times 40 Under 40 in 2021, Fortune 40 Under 40 in 2020, Endpoints 20 Under 40 in 2020, Goldman Sachs 100 Most Intriguing Entrepreneurs in 2019, and Business Insider’s 30 Biotech Leaders Under 40 Shaping the Future of Medicine in 2017.

About Encoded Therapeutics

Encoded Therapeutics focuses on developing precision gene therapies for pediatric central nervous system disorders, with its leading program, ETX101, targeting Dravet syndrome.

report flag Report inaccurate information

People similar to Kartik Ramamoorthi

Stephanie Tagliatela

Co-founder, Chief Scientific Officer & Board Member @ Encoded Therapeutics

Stephanie Tagliatela is a co-founder, Chief Scientific Officer, and Board Member, recognized as one of the top 30 biotech leaders under 40 by Business Insider for her contributions to the field.

Sal Rico

Chief Medical Officer @ Encoded Therapeutics

Sal Rico is the Chief Medical Officer with a strong background in pharmacology and clinical development, known for leading the development of gene therapies and contributing to the regulatory approval of various medical products.

Andrew Stober

Chief Manufacturing Officer @ Encoded Therapeutics

Andrew Stober is a seasoned manufacturing executive in the biotechnology sector, currently serving as the Chief Manufacturing Officer, with extensive experience in gene therapy manufacturing and supply chain operations.

Unlock exclusive insights

Sign up to reveal more information.

loader Sign up for free